Texas 2009 - 81st Regular

Texas House Bill HB142

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to disease control programs to reduce the risk of certain communicable diseases.

Impact

The introduction of HB 142 is expected to have a significant impact on public health initiatives regarding drug use and the spread of communicable diseases. Local health authorities would be empowered to implement programs that could mitigate the risks associated with needle sharing, potentially leading to a decrease in the rates of infections related to drug use. By facilitating access to new needles, the programs aim to limit the transmission of diseases, supporting broader health goals within Texas.

Summary

House Bill 142 is focused on establishing disease control programs that aim to reduce the risk of certain communicable diseases such as HIV, hepatitis B, and hepatitis C. The bill authorizes local health authorities or organizations contracting with local governments to create programs designed to facilitate the anonymous exchange of used hypodermic needles for new hypodermic needles. Furthermore, the bill provides for education on the transmission and prevention of these diseases as well as facilitating access to health-related services, including substance abuse treatment and testing for bloodborne diseases.

Contention

Although the bill aims to address critical health issues, it may face opposition from those who are concerned about the implications of needle exchange programs. Critics could argue that such programs might inadvertently condone drug use, while supporters would emphasize the public health benefits. Additionally, there may be contention regarding the establishment and funding of these programs, particularly regarding the fees imposed on participants for needle exchange, which must not exceed 150% of the actual cost.

Companion Bills

TX SB188

Identical Relating to disease control outreach programs to reduce the risk of certain communicable diseases.

Previously Filed As

TX HB1403

Relating to the establishment by certain counties and hospital districts of disease control pilot programs to reduce the risk of certain infectious and communicable diseases; authorizing fees.

TX HB1593

Relating to infection prevention and control programs and other measures for communicable diseases at certain long-term care facilities; authorizing an administrative penalty.

TX HB119

Relating to judicial review of certain orders issued to address a declared state of disaster, declared public health disaster, or ordered public health emergency or to prevent the spread of a communicable disease.

TX SB310

Relating to limitations on public health directives issued during a state of disaster or outbreak of a communicable disease.

TX SB700

Relating to the implementation by public schools of certain communicable disease public health orders issued by a health authority.

TX HB987

Relating to equipment used or intended for use in testing or analyzing a controlled substance.

TX HB1365

Relating to equipment used or intended for use in testing or analyzing a controlled substance.

TX SB623

Relating to equipment used or intended for use in testing or analyzing a controlled substance.

TX HB224

Relating to removing criminal penalties for the possession or distribution of certain drug paraphernalia under the Texas Controlled Substances Act.

TX HB1341

Relating to repealing certain offenses and removing certain regulations relating to the cultivation, manufacture, delivery, and possession of marihuana and cannabis.

Similar Bills

MS HB410

Hypodermic syringes or needles; unlawful to sell, obtain, purchase or possess as a direct consumer without a written prescription.

CA AB2077

Hypodermic needles and syringes.

CA AB309

Hypodermic needles and syringes.

SC S0255

Safer Syringe Program

NJ A2800

Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.

NJ S1077

Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.

NJ A1843

Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.

IL HB2118

HYPODERMIC SYRINGES-SALE